Current Report Filing (8-k)

Date : 11/07/2018 @ 11:23AM
Source : Edgar (US Regulatory)
Stock : Marimed Inc. (QB) (MRMD)
Quote : 2.2  -0.01 (-0.45%) @ 7:12PM

Current Report Filing (8-k)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 7, 2018

 

MARIMED INC.
(Exact name of registrant as specified in its charter)

 

Delaware   0-54433   27-4672745
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

10 Oceana Way, Norwood, Massachusetts   02062
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (617) 795-5140

 

26 Ossipee Road, Newton, Massachusetts 02464

(Former address of principal executive offices)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

     
 

 

Item 8.01. Other Events.

 

On November 7, 2018, we issued a press release announcing (i) the hiring of Charles Finnie as Chief Strategy Officer, and (ii) the plan to implement a new strategic initiative designed to increase revenues.

 

A copy of such release is annexed hereto as an exhibit.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

  Exhibit   Description
       
  99.1   November 7, 2018 Press Release

 

     
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MARIMED INC.
     
Dated:  November 7, 2018    
  By: /s/ ROBERT FIREMAN
    Robert Fireman, CEO

 

     
 

 

EXHIBIT INDEX

 

  Exhibit   Description
       
  99.1   November 7, 2018 Press Release

 

     
 

 

MariMed Inc. (USOTC:MRMD)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more MariMed Inc. Charts.

MariMed Inc. (USOTC:MRMD)
Intraday Stock Chart

Today : Monday 24 June 2019

Click Here for more MariMed Inc. Charts.

Latest MRMD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.